Biodefense — AI news & analysis

OpenAI launches Rosalind Biodefense — restricted-access life-sciences model goes to Johns Hopkins APL, CEPI, US government partners

OpenAI launched Rosalind Biodefense on May 29, 2026, expanding restricted access to its GPT-Rosalind life-sciences model. Vetted developers and US government partners get sponsored access to build epidemiological modeling, early-detection, screening, and pandemic-preparedness applications. Named partners include Johns Hopkins Applied Physics Laboratory (protein engineering for therapeutics + biothreat characterization) and the Coalition for Epidemic Preparedness Innovations (100 Days Mission for vaccine acceleration). OpenAI's mirror-image answer to Anthropic's Project Glasswing — same restricted-access frontier-model pattern, applied to life sciences instead of cybersecurity.